A Phase II Clinical Study Evaluating the Safety, Tolerability,Pharmacokinetics, and Preliminary Efficacy of JS212 andJS213 as Monotherapy and in Combination in Patients Withadvanced Malignant Solid Tumors
Shanghai Junshi Bioscience Co., Ltd.
Shanghai Junshi Bioscience Co., Ltd.
MediLink Therapeutics (Suzhou) Co., Ltd.
Nanjing Leads Biolabs Co.,Ltd
Sichuan Huiyu Pharmaceutical Co., Ltd
Nanjing Leads Biolabs Co.,Ltd
Nanolattix Biotechnology Co., Ltd.
Nanjing Leads Biolabs Co.,Ltd
Bio-Thera Solutions
Nanjing Leads Biolabs Co.,Ltd
NextCure, Inc.
Ascentage Pharma Group Inc.
Minghui Pharmaceutical (Hangzhou) Ltd
RemeGen Co., Ltd.
Shanghai Institute Of Biological Products
RemeGen Co., Ltd.
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Changchun GeneScience Pharmaceutical Co., Ltd.
Changchun GeneScience Pharmaceutical Co., Ltd.
Suzhou Suncadia Biopharmaceuticals Co., Ltd.